Toll-like receptor signaling in sepsis

Current Opinion in Pediatrics

Volumn 15, Issue 3, 2003, Pages 278-282

  Lakhani, Saquib A ^a   Bogue, Clifford W ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; TOLL LIKE RECEPTOR;

DRUG TARGETING; IMMUNE SYSTEM; INFLAMMATION; INTENSIVE CARE; MAMMAL; MICROORGANISM; MOLECULAR BIOLOGY; NONHUMAN; PRIORITY JOURNAL; REVIEW; SEPSIS; SIGNAL TRANSDUCTION;

HUMANS; LIPOPOLYSACCHARIDES; MEMBRANE GLYCOPROTEINS; RECEPTORS, CELL SURFACE; SEPSIS; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTORS;

EID: 0037952671     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008480-200306000-00009     Document Type: Review

References (38)

1. Hashimoto C, Hudson KL, Anderson KV: The Toll gene of Drosophila, required for dorsal-ventral embryonic polarity, appears to encode a transmembrane protein. Cell 1988, 52:269-279.
2. Belvin MP, Anderson KV: A conserved signaling pathway: the Drosophila toll-dorsal pathway. Annu Rev Cell Dev Biol 1996, 12:393-416.
3. Lemaitre B, et al.: The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell 1996, 86:973-983.
4. Medzhitov R, Preston-Hurlburt P, Janeway Jr CA: A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature, 1999, 388:394-397.
5. Akira S: Mammalian Toll-like receptors. Curr Opin Immunol 2003, 15:5-11.
6. Vasselon T, Detmers PA: Toll receptors: a central element in innate immune responses. Infect Immun 2002, 70:1033-1041.
7. Martin MU, Wesche H: Summary and comparison of the signaling mechanisms of the Toll/interleukin-1 receptor family. Biochim Biophys Acta 2002, 1592:265-280.
8. Wright SD, et al.: CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 1990, 249:1431-143.
9. Schumann RR, et al.: Structure and function of lipopolysaccharide binding protein. Science 1990, 249:1429-1431.
10. Haziot A, et al.: Resistance to endotoxin shock and reduced dissemination of gram- negative bacteria in CD14-deficient mice. Immunity 1996, 4:407-414.
11. Knuefermann P, et al.: CD14-deficient mice are protected against lipopolysaccharide-induced cardiac inflammation and left ventricular dysfunction. Circulation, 2002, 106:2608-2615. Wild-type and CD14-deficient mice were injected with E. coli LPS. Wild-type mice had an increase in myocardial NF-κB activation, cytokine mRNA production, and hemodynamic parameters showing depressed left ventricular function. CD14-deficient mice, on the other hand, had lower levels of NF-κB activation and cytokine mRNA production, and also retained normal reft ventricular function. These findings strongly suggest that the TLR4-CD14 pathway is involved in the pathophysiology of depressed cardiac function seen in sepsis.
12. Sultzer BM: Genetic control of leukocyte responses to endotoxin. Nature 1968, 219:1253-1254.
13. Poltorak A, et al.: Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in TLR4 gene. Science 1998, 282:2085-2088.
14. Qureshi ST, et al.: Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (TLR4). J Exp Med 1999, 189:615-625.
15. Hoshino K, et al.: Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J Immunol 1999, 162:3749-3752.
16. Shimazu R, et al.: MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll- like receptor 4. J Exp Med 1999, 189:1777-1782.
17. Schromm AB, et al.: Molecular genetic analysis of an endotoxin nonresponder mutant cell line: a point mutation in a conserved region of MD-2 abolishes endotoxin-induced signaling. J Exp Med 2001, 194:79-88.
18. Nagai Y, et al.: Essential role of MD-2 in LPS responsiveness and TLR4 distribution, Nat Immunol 2002, 3:667-672. This paper shows that MD-2 knockout mice are resistant to LPS and endotoxic shock, but remain susceptible to Salmonella typhimurium infection, a phenotype similar to TLR4 knockout mice. In the absence of MD-2, TLR4 was confined to the Golgi, indicating that MD-2 plays a role in the intracellular distribution of TLR4 in the LPS response.
19. Hajjar AM, et al.: Human Toll-like receptor 4 recognizes host-specific LPS modifications. Nat Immunol 2002, 3:354-359. This paper demonstrates that human, but not mouse, TLR4 is capable of recognizing different forms of LPS produced by Pseudomonas aeruginosa through an extracellular hypervariable region in TLR4. This may represent one paradigm explaining species-specific variability in the inflammatory response to LPS.
20. Armant MA, Fenton MJ: Toll-like receptors: a family of pattern-recognition receptors in mammals. Genome Biol 2002, 3:3011.
21. Shelton CA, Wasserman SA: Pelle encodes a protein kinase required to establish dorsoventral polarity in the Drosophila embryo. Cell 1993, 72:515-525.
22. Grosshans J, et al.: Activation of the kinase Pelle by Tube in the dorsoventral signal transduction pathway of Drosophila embryo. Nature 1994, 372:563-566.
23. Muzio M, et al.: IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling. Science 1997, 278:1612-1615.
24. Wesche H, et al.: MyD88: an adapter that recruits IRAK to the IL-1 receptor complex. Immunity 1997, 7:837-847.
25. Medzhitov R, et al.: MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways. Mol Cell 1998, 2:253-258.
26. Fitzgerald KA, et al.: Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction. Nature 2001, 413:78-83.
27. Horng T, Barton GM, Medzhitov R: TIRAP: an adapter molecule in the Toll signaling pathway. Nat Immunol 2001, 2:835-841.
28. Yamamoto M, et al.: Essential role for TIRAP in activation of the signaling cascade shared by TLR2 and TLR4. Nature 2002, 420:324-329.
29. Oshiumi H, et al.: TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-beta induction. Nat Immunol 2003, 4:161-167.
30. Kanakaraj P, et al.: Interleukin (IL)-1 receptor-associated kinase (IRAK) requirement for optimal induction of multiple IL-1 signaling pathways and IL-6 production. J Exp Med 1998, 187:2073-2079.
31. Thomas JA, et al.: Impaired cytokine signaling in mice lacking the IL-1 receptor-associated kinase. J Immunol 1999, 163:978-984.
32. Suzuki N, et al.: Severe impairment of interleukin-1 and Toll-like receptor signaling in mice lacking IRAK-4. Nature 2002, 416:750-756. Mice deficient in IRAK-4 are shown to be resistant to endotoxic shock and to have an abolished response to IL-1, indicating a key role for this kinase in signaling downstream from TLR.
33. Kobayashi K, et al.: IRAK-M is a negative regulator of Toll-like receptor signaling. Cell, 2002, 110:191-202. IRAK-M-deficient mice show an enhanced inflammatory response, identifying this kinase as the only member of its family known to negatively regulate TLR signaling.
34. Leturcq DJ, et al.: Antibodies against CD14 protect primates from endotoxin-induced shock. J Clin Invest 1996, 98:1533-1538.
35. Schimke J, et al.: Anti-CD 14 mAb treatment provides therapeutic benefit after in vivo exposure to endotoxin. Proc Natl Acad Sci U S A 1998, 95:13875-13880.
36. Verbon A, et al.: IC14, an anti-CD14 antibody, inhibits endotoxin-mediated symptoms and inflammatory responses in humans. J Immunol 2001, 166:3599-3605. In a study of the protective effects of blocking CD14-TLR4 signaling, IC14 attenuated clinical symptoms and decreased the production of proinflammatory cytokines in volunteers injected with LPS. First published study looking at blockade of this pathway in humans.
37. Kurt-Jones EA, et al.: Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat Immunol 2000, 1:398-401.
38. Haeberle HA, et al.: Respiratory syncytial virus-induced activation of nuclear factor-kappaB in the lung involves alveolar macrophages and toll-like receptor 4- dependent pathways. J Infect Dis 2002, 186:1199-206.